Clinical Trials Logo

Clinical Trial Summary

This study aims to examine whether the pain of topical photodynamic therapy (PDT) is significantly different when using low irradiance ambulatory light emitting diode (LED) devices compared with conventional higher irradiance hospital based LED light sources when used for superficial non-melanoma skin cancer. The investigators are also investigating the phototoxicity and efficacy of each regime in this randomized assessor-blinded clinical trial.


Clinical Trial Description

A randomized assessor-blinded comparative study of low irradiance ambulatory LED devices with conventional hospital-based LED devices for superficial non-melanoma skin cancer. Preliminary observations suggest that low irradiance LEDs cause less pain but are as effective, so the investigators are examining this in a clinical trial of patients with lesions </= 2cm diameter of non-melanoma skin cancer (Bowen's disease and superficial basal cell carcinoma). Patients with these conditions referred to the PDT clinic will be invited to participate and if they are eligible and consent to treatment then they will be prospectively randomized to either ambulatory PDT or conventional PDT. Pain and phototoxicity scores will be recorded and clinical efficacy will be assessed up to one year after the last treatment. Computer-generated block randomization will be performed and at 90% power to detect as significant at the 5% level a mean difference in pain score of 2 in one group compared with 4 in the other, 36 patients will be needed, and as the participants will often be elderly and frail the investigators will aim for a safety margin of recruiting 50 participants to account for drop-outs. Participants will receive two treatments of either arm at a one week interval and will be assessed clinically at three months and if residual disease remains then the two treatments a week apart are repeated. Pain assessed using a visual analogue scale (VAS) score and phototoxicity on a semi-quantitative scale are recorded at 7 days when the participant returns for their second treatment. Follow up for clinical assessment is at 6 months and one year after treatment. Participants also give their opinion of treatment at one year follow up. Assessors of adverse effects and efficacy will be blinded. Data recording and analysis will be undertaken by the study statistician Dr Robert Dawe and analysis will be on an intention to treat basis using appropriate statistical tests comparing the pre-planned outcome measures, with pain as primary outcome and outcome, efficacy and patient satisfaction as secondary outcomes ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02872909
Study type Interventional
Source University of Dundee
Contact
Status Completed
Phase N/A
Start date October 2011
Completion date February 6, 2017

See also
  Status Clinical Trial Phase
Not yet recruiting NCT04103658 - NIR and Skin Cancer Margins N/A
Completed NCT01053819 - Can We Miss Pigmented Lesions in Psoriasis Patients? Phase 4
Recruiting NCT03767348 - Study of RP1 Monotherapy and RP1 in Combination With Nivolumab Phase 2
Recruiting NCT05429866 - Immunological Variables Associated to ICI Toxicity in Cancer Patients Phase 2
Active, not recruiting NCT02636569 - Topical Chemoprevention of Skin Cancer Biomarkers Phase 2
Completed NCT02760160 - Dietary Prevention of Photodamage in Skin With Grapes N/A
Completed NCT02780934 - Comparing Pressure Versus Simple Adhesive Dressing After Mohs Reconstruction N/A
Withdrawn NCT03327064 - A Biomarker Evaluation Trial of UAB30 in Renal Transplant Recipients at High Risk for Non-melanoma Skin Cancer Phase 1/Phase 2
Completed NCT00342407 - The Incidence of Breast and Other Cancers Among Female Flight Attendants
Terminated NCT04410874 - Imvamune Vaccine for the Treatment of Non-melanoma Skin Cancer Phase 1/Phase 2
Completed NCT03693937 - A Retrospective Evaluation of Superficial Radiation Therapy (SRT) and Non-Melanoma Skin Cancer (NMSC)
Completed NCT04334824 - Hydrochlorothiazide and Risk of Skin Cancer
Recruiting NCT05878288 - Deep sequencIng in Cutaneous Squamous CEll caRciNomas Phase 2
Completed NCT01359735 - Healing Effects of HP802-247 Versus Antibiotic Ointment in Mohs Micrographic Surgery Patients Phase 2
Terminated NCT04348916 - Study of ONCR-177 Alone and in Combination With PD-1 Blockade in Adult Subjects With Advanced and/or Refractory Cutaneous, Subcutaneous or Metastatic Nodal Solid Tumors or With Liver Metastases of Solid Tumors Phase 1
Enrolling by invitation NCT05257486 - Post-market Multi-Center RETRO-Prospective Study to Assess Long-term Clinical Outcomes NMSC Patients Treated With eBx
Recruiting NCT06428721 - The Preventive Role of Fractionated Laser Resurfacing Against Actinic Neoplasia in an At-Risk Geriatric Population N/A
Withdrawn NCT03757663 - UV Dosimetry Feedback in NMSC Patients N/A
Completed NCT04116983 - DERM NMSC Validation Study
Active, not recruiting NCT06227416 - Skin Tumor Biomarkers by Mass Spectrometry Imaging N/A